[Diagnosis and treatment guidelines for difficult-to-control asthma in children]

M Navarro Merino1, A Andrés Martín, O Asensio de la Cruz

  • 1Sección de Neumología Pediátrica, Hospital Universitario Virgen Macarena, Sevilla, España. mnavarro1@us.es

Insights

Difficult-to-control asthma (DCA) in children requires careful diagnosis to exclude mimics and assess compliance. Phenotyping DCA through inflammation studies aids in tailored therapeutic decisions for better asthma management.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Respiratory Medicine

Context:

  • Difficult-to-control asthma (DCA) affects a small percentage of pediatric asthma patients, leading to significant healthcare utilization.
  • Accurate characterization of DCA is crucial to differentiate it from conditions mimicking asthma and to identify contributing factors like comorbidities or environmental influences.
  • Poor treatment compliance is a common issue that needs thorough evaluation in cases of suspected DCA.

Purpose:

  • To outline the diagnostic challenges and necessary evaluations for children with difficult-to-control asthma.
  • To emphasize the importance of differential diagnosis to rule out asthma mimics and contributing factors.
  • To highlight the role of inflammation studies and clinical assessments in phenotyping DCA for optimized treatment.

Summary:

  • DCA necessitates comprehensive evaluation, including differential diagnosis to exclude mimics and assessment of environmental, psychological, and comorbidity factors.
  • Identifying reasons for poor treatment compliance is essential in managing pediatric DCA.
  • Inflammation studies (e.g., exhaled nitric oxide, induced sputum) and pulmonary function tests help classify DCA into distinct phenotypes, guiding therapeutic strategies.

Impact:

  • Improved diagnostic accuracy for pediatric difficult-to-control asthma.
  • Facilitation of personalized treatment plans based on identified DCA phenotypes.
  • Potential reduction in hospital admissions and healthcare costs associated with uncontrolled pediatric asthma.

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...